ERBB2 and non-small cell lung carcinoma: As a diagnostic marker for lung cancer, HER2 overexpression is predominantly observed in adenocarcinomas and large cell carcinomas (LCCs), with a reduced frequency in non-small cell lung cancer (NSCLC) tumors (Abu Al Karsaneh et al., 2023).